Berger, Tamar https://orcid.org/0000-0001-5547-6936
Shochat, Tzippy
Aumann, Shlomzion
Nachmias, Boaz
Goldschmidt, Neta
Horesh, Nurit
Harel, Reut
Aviv, Ariel
Shmerts, Ella
Abadi, Uri
Shimony, Shai
Raanani, Pia
Gafter‑Gvili, Anat
Gurion, Ronit
Article History
Received: 3 March 2023
Accepted: 29 May 2023
First Online: 19 June 2023
Declarations
:
: All procedures performed in studies involving human participants were in accordance with the ethical standards of the institutional research committee and with the 1964 Helsinki Declaration and its later amendments or comparable ethical standards. Approval was obtained from Rabin Medical Center (RMC) Institutional Review Board (IRB) ethics committee.
: Informed consent was waived due to the retrospective design of the study.
: Tamar Berger—Janseen (honoraria, advisory committee), Neopharm (advisory committee).Boaz Nachmias—AbbVie (consultant, honoraria, research funding).Pia Raanani—Pfizer (advisory board, consultancy, research support, speaker’s bureau); Novartis (consultancy, research support); BMS (consultancy); Janssen (speaker’s bureau).Ronit Gurion—Roche, Gilead, Medison Ltd, Novartis, and Takeda (honoraria and advisory committee).All other authors have no relevant financial or non-financial interests to disclose.